Literature DB >> 9443853

Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples.

P Anzenbacher1, P Soucek, E Anzenbacherová, I Gut, K Hrubý, Z Svoboda, J Kvĕtina.   

Abstract

Cytochrome P450 (CYP) of the 3A family (CYP3A) has been detected in minipig liver microsomes by immunochemical screening (Western blotting), revealing bands that co-migrate with human CYP3A4 and 3A5. The nifedipine oxidase activity and testosterone 6beta-hydroxylating activity (specific markers for CYP3A enzymes) of the human liver microsomal and minipig liver microsomal samples were comparable, as were the results of specific inhibition of this activity by triacetyloleandomycin. The presence of CYP1A, 2A, 2C, 2D, and 2E1 marker activities in minipig liver microsomes was found by testing with the respective specific substrates (7-ethoxyresorufin, coumarin, tolbutamide, bufuralol, and chlorzoxazone). 7-Pentoxyresorufin O-depentylase activity (indicative of CYP2B) was absent from minipig as well as human liver microsomal samples. The results indicate that minipigs might be, in many cases, the most suitable experimental animals to predict biotransformation pathways in humans, because the activity of the most important CYP isoform in humans (CYP3A, metabolizing the majority of known drug substrates) is present in minipigs, with comparable levels and activities. Moreover, there is no need to induce CYP enzyme levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443853

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  17 in total

Review 1.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

2.  In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs.

Authors:  Els Van Peer; Frank Jacobs; Jan Snoeys; Jos Van Houdt; Ils Pijpers; Christophe Casteleyn; Chris Van Ginneken; Steven Van Cruchten
Journal:  Pharm Res       Date:  2017-01-17       Impact factor: 4.200

Review 3.  Porcine cytochrome P450 3A: current status on expression and regulation.

Authors:  Martin Krøyer Rasmussen
Journal:  Arch Toxicol       Date:  2020-03-14       Impact factor: 5.153

4.  Analysis of substrate specificity of pig CYP2B22 and CYP2C49 towards herbicides by transgenic rice plants.

Authors:  Hiroyuki Kawahigashi; Sakiko Hirose; Kenjirou Ozawa; Yoshiko Ido; Misaki Kojima; Hideo Ohkawa; Yasunobu Ohkawa
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 2.788

5.  Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs.

Authors:  P Soucek; R Zuber; E Anzenbacherová; P Anzenbacher; F P Guengerich
Journal:  BMC Pharmacol       Date:  2001-12-05

6.  The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.

Authors:  Viktor Hlaváč; Veronika Brynychová; Radka Václavíková; Marie Ehrlichová; David Vrána; Václav Pecha; Markéta Trnková; Roman Kodet; Marcela Mrhalová; Kateřina Kubáčková; Jiří Gatěk; Petr Vážan; Pavel Souček
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

7.  Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates.

Authors:  Carmen Rey-Santano; Victoria Mielgo; Adolfo Valls-I-Soler; Esther Encinas; John C Lukas; Valvanera Vozmediano; Elena Suárez
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

Review 8.  Regulation of porcine hepatic cytochrome p450 - implication for boar taint.

Authors:  Martin Krøyer Rasmussen; Galia Zamaratskaia
Journal:  Comput Struct Biotechnol J       Date:  2014-09-10       Impact factor: 7.271

9.  Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.

Authors:  Nadine Schaefer; Mattias Kettner; Matthias W Laschke; Julia Schlote; Andreas H Ewald; Michael D Menger; Hans H Maurer; Peter H Schmidt
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

10.  Cecropin B Represses CYP3A29 Expression through Activation of the TLR2/4-NF-κB/PXR Signaling Pathway.

Authors:  Xiaoqiao Zhou; Xiaowen Li; Xiliang Wang; Xiue Jin; Deshi Shi; Jun Wang; Dingren Bi
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.